SCHEMBL16307170

SCHEMBL16307170

Cc1cc(-c2cnc3c(NCCC(F)(F)F)cc(Oc4ccc(O)c(F)c4F)nn23)ccc1C(=O)NC1CC1

nearest known ligand 0.88

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TTK P33981 20/20 0.88

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bay-1217389 SCHEMBL30381937 0.94 TTK (1.00) TTK
Bay-1217389 SCHEMBL15555839 0.94 TTK (1.00) TTK
SCHEMBL17559993 0.94 TTK (0.90) TTK
SCHEMBL458190 0.90 TTK (0.83) TTK
SCHEMBL469942 0.90 TTK (0.79) TTK
SCHEMBL17571044 0.89 TTK (0.91) TTK
SCHEMBL458506 0.89 TTK (0.81) TTK
SCHEMBL15556230 0.89 TTK (0.81) TTK
SCHEMBL455716 0.89 TTK (0.81) TTK
SCHEMBL457588 0.88 TTK (0.80) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014198776-A1 COMBINATION OF A IMIDAZOPYRIDAZINE DERIVATIVE AND A MITOTIC AGENT FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-12-18 — — WO disclosed
Send feedback